Expand COCH Menu
COCH MENU

COCH Latest Press Releases

-- June 23, 2026 --

Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th Globe Newswire 8:35 AM

-- June 18, 2026 --

Envoy Medical to Present at Investor Conferences on June 25th Newsfile 8:31 AM

-- June 4, 2026 --

Envoy Medical to Present at Planet MicroCap Conference Las Vegas on June 16th-18th Newsfile 8:31 AM

-- May 20, 2026 --

Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology Newsfile 8:30 AM

-- May 11, 2026 --

Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant Newsfile 8:00 AM

-- April 28, 2026 --

Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant Newsfile 8:30 AM

-- April 22, 2026 --

Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant Newsfile 8:00 AM

-- April 16, 2026 --

Envoy Medical Appoints Chas McKhann to Board of Directors Newsfile 8:00 AM

-- April 1, 2026 --

Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant Newsfile 8:00 AM

-- March 23, 2026 --

Envoy Medical Reports Full Year 2025 Financial Results Newsfile 8:30 AM

-- March 11, 2026 --

Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant Newsfile 8:01 AM

-- February 24, 2026 --

Envoy Medical Regains Compliance with Nasdaq Listing Requirement Newsfile 8:01 AM

-- February 23, 2026 --

Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space Newsfile 8:01 AM

-- February 19, 2026 --

Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial Newsfile 8:01 AM

-- February 17, 2026 --

Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant Newsfile 8:00 AM

-- February 12, 2026 --

Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering Newsfile 4:05 PM

-- February 11, 2026 --

Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering Newsfile 9:25 AM

-- February 6, 2026 --

Small Cap Growth Virtual Investor Conference: Presentations Now Available for On-Demand Viewing Globe Newswire 8:35 AM

-- February 2, 2026 --

Small Cap Growth Virtual Investor Conference Agenda Announced for February 5th Globe Newswire 8:35 AM

-- January 29, 2026 --

Envoy Medical to Present at the Small Cap Growth Virtual Investor Conference February 5 Globe Newswire 8:35 AM
Market Data Delayed 15 Minutes